Aurora Cannabis Inc. said Monday it intends to acquire the one of the last independent members of the so-called “blessed eight,” a group of marijuana companies given the first approval to move cannabis genetics from the black market into the legal regime.
Aurora ACB, +4.28% ACB, +6.26% said it would pay up to C$175 million ($132 million) in stock for Whistler Medical Marijuana Corp., a privately held British Columbia-based producer of cannabis, which is known in Canada for its ability to produce organic cannabis. “I would call [Whistler] the crown jewel of organic cannabis production world-wide,” Aurora Chief Corporate Officer Cam Battley said in a phone interview. “It’s the first organic-certified company, and now we’ve essentially got the market to ourselves.”
Battley said Whistler will help with its near-term strategy of growing cannabis itself until the company is able to secure high-quality product from suppliers at a low enough price, which at the moment isn’t possible. [Read more at Market Watch]
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers